Additional work demonstrated that deficient UPR activation is caused by reduced transcription of the UPR target genes XBP1, GRP94, and CHOP in lymphoblast cells from BD patients after treatment with the ER stressors thapsigargin (TG) and tunicamycin (Tun) (So et al., 2007; Hayashi et al., 2009; Bengesser et al., 2018). The gene discussed is DDIT3; the disease is Behcet disease.